D-1274-2020 Class II Terminated

Recalled by West-Ward Columbus Inc — Columbus, OH

FDA drug recall D-1274-2020 was initiated by West-Ward Columbus Inc on May 13, 2020 and is designated Class II. Reason for recall: Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result. The recall status is terminated (terminated Mar 25, 2023). Affected quantity: 68,376 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 3, 2020
Initiation Date
May 13, 2020
Termination Date
Mar 25, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
68,376 bottles

Product description

Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 0143-2112-05), Rx only, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724.

Reason for recall

Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.

Distribution pattern

USA Nationwide

Code information

Lot #: a) 71846B, Exp 6/2021; b) 71726A, Exp 6/2020; 71846B, 71853A, Exp 6/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1274-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1274-2020. Report a data issue: hello@regdatalab.com.